1. Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2 in vitro and in vivo. (10th February 2023) Authors: Kuroda, Takayuki; Nobori, Haruaki; Fukao, Keita; Baba, Kaoru; Matsumoto, Kazumi; Yoshida, Shinpei; Tanaka, Yukari; Watari, Ryosuke; Oka, Ryoko; Kasai, Yasuyuki; Inoue, Kae; Kawashima, Sho; Shimba, Alice; Hayasaki-Kajiwara, Yoko; Tanimura, Miki; Zhang, Qianhui; Tachibana, Yuki; Kato, Teruhisa; Shi... Journal: Journal of antimicrobial chemotherapy Issue: Volume 78:Number 4(2023) Page Start: 946 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse model. (2nd August 2022) Authors: Nobori, Haruaki; Fukao, Keita; Kuroda, Takayuki; Anan, Naomi; Tashima, Ryoichi; Nakashima, Masaaki; Noda, Sayuri; Tajiri, Minako; Torii, Mikinori; Toba, Shinsuke; Uemura, Kentaro; Sanaki, Takao; Shishido, Takao; Tachibana, Yuki; Kato, Teruhisa Journal: Journal of antimicrobial chemotherapy Issue: Volume 77:Number 11(2022) Page Start: 2984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗